[go: up one dir, main page]

MX2011007101A - Composiciones de hidrolizados proteicos que tienen capacidad mejorada para liberar colecistocinina (cck). - Google Patents

Composiciones de hidrolizados proteicos que tienen capacidad mejorada para liberar colecistocinina (cck).

Info

Publication number
MX2011007101A
MX2011007101A MX2011007101A MX2011007101A MX2011007101A MX 2011007101 A MX2011007101 A MX 2011007101A MX 2011007101 A MX2011007101 A MX 2011007101A MX 2011007101 A MX2011007101 A MX 2011007101A MX 2011007101 A MX2011007101 A MX 2011007101A
Authority
MX
Mexico
Prior art keywords
protein hydrolysate
releasing ability
hydrolysate compositions
enhanced
cck releasing
Prior art date
Application number
MX2011007101A
Other languages
English (en)
Inventor
Theodore M Wong
Jason F Lombardi
Elaine Krul
Charles S Schasteen
Original Assignee
Solae Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42077654&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2011007101(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Solae Llc filed Critical Solae Llc
Publication of MX2011007101A publication Critical patent/MX2011007101A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
    • A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C21/00—Whey; Whey preparations
    • A23C21/08—Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/60—Drinks from legumes, e.g. lupine drinks
    • A23L11/65—Soy drinks
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Grain Derivatives (AREA)

Abstract

La presente invención proporciona composiciones de hidrolizados proteínicos que tienen actividad mejorada para liberar colecistocinina (CCK) y que pueden usarse para promover la saciedad.
MX2011007101A 2008-12-31 2009-12-30 Composiciones de hidrolizados proteicos que tienen capacidad mejorada para liberar colecistocinina (cck). MX2011007101A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14193108P 2008-12-31 2008-12-31
PCT/US2009/069867 WO2010078461A1 (en) 2008-12-31 2009-12-30 Protein hydrolysate compositions having enhanced cck releasing ability

Publications (1)

Publication Number Publication Date
MX2011007101A true MX2011007101A (es) 2011-08-04

Family

ID=42077654

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011007101A MX2011007101A (es) 2008-12-31 2009-12-30 Composiciones de hidrolizados proteicos que tienen capacidad mejorada para liberar colecistocinina (cck).

Country Status (11)

Country Link
US (1) US20110257087A1 (es)
EP (3) EP2856885A3 (es)
JP (1) JP2012513771A (es)
CN (1) CN102361560A (es)
BR (1) BRPI0918708A2 (es)
CA (1) CA2747749A1 (es)
ES (1) ES2429311T3 (es)
MX (1) MX2011007101A (es)
RU (1) RU2011132135A (es)
SG (1) SG172824A1 (es)
WO (1) WO2010078461A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2299839A2 (en) * 2008-06-20 2011-03-30 Solae, Llc Protein hydrolysate compositions stable under acidic conditions
EP2436389A1 (en) * 2010-10-01 2012-04-04 Nestec S.A. Milk-based protein hydrolysates and infant formulae and nutritional compositions made thereof
MX2013009772A (es) * 2011-02-23 2013-10-01 Solae Llc Composiciones de hidrosilato de proteinas que tienen actividad liberadora mejorada de colecistoquina (cck) y peptido similar a glucagon-1 (glp-1).
WO2013092851A1 (en) 2011-12-21 2013-06-27 Laboratorios Ordesa, S.L. Process for obtaining rice protein hydrolysates useful in the prevention and/or treatment of obesity
EP2948170B1 (en) * 2013-01-23 2020-08-19 Alvine Pharmaceuticals, Inc. Pharmaceutical compositions for treating celiac disease and gluten intolerance
WO2014114939A1 (en) 2013-01-23 2014-07-31 Bottled Science Limited Skin enhancing beverage composition
EP2948468A1 (en) 2013-01-28 2015-12-02 Solae, LLC Novel polypeptides having satiety hormone releasing activity
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
WO2014138304A1 (en) 2013-03-08 2014-09-12 Axiom Foods, Inc., Rice protein supplements
RU2536967C1 (ru) * 2013-11-05 2014-12-27 Общество с ограниченной ответственностью "Зеленые линии" Способ получения пищевого продукта с пенообразующими свойствами
KR101531479B1 (ko) * 2014-11-21 2015-06-26 세원셀론텍(주) 의료용 재료로 사용하기 위한 고농도 콜라겐 제조방법
EP3804532B1 (en) 2015-03-30 2024-12-25 Société des Produits Nestlé S.A. Milk-based protein hydrolysates and compositions made thereof
US11219663B2 (en) * 2015-07-27 2022-01-11 Suntory Holdings Limited Composition containing cyclic dipeptide and sweetening agent
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的系统和方法
WO2020092432A1 (en) 2018-10-30 2020-05-07 Michael Foods, Inc. Crisped proteinaceous food product
JP7326022B2 (ja) * 2019-05-17 2023-08-15 ユニ・チャーム株式会社 ペットフード
EP4274423A1 (en) * 2021-01-05 2023-11-15 Novozymes A/S Process for preparing a plant-based fermented dairy alternative
CN116082451B (zh) * 2022-12-16 2024-08-27 上海理工大学 一种荞麦源促胆囊收缩素分泌肽及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1162338B (it) 1978-07-04 1987-03-25 Novo Industri As Composizione a base di proteasi con ridotta allergenicita' e procedimento di preparazione
US5288627A (en) 1988-01-07 1994-02-22 Novo Nordisk A/S Endoprotease from Fusarium oxysporumDSM 2672 for use in detergents
CA2003078A1 (en) 1988-11-18 1990-05-18 Alan Sloma Protease deletion
DK19991D0 (da) 1991-02-06 1991-02-06 Novo Nordisk As Proteinpraeparationer
DK63490D0 (da) 1990-03-09 1990-03-09 Novo Nordisk As Fremgangsmaade til fremstilling af ost
ATE126970T1 (de) 1990-03-09 1995-09-15 Novo Nordisk As Proteinhydrolysate.
JP3046344B2 (ja) 1990-10-24 2000-05-29 塩野義製薬株式会社 新規プロテアーゼ
DK52393D0 (es) 1993-05-05 1993-05-05 Novo Nordisk As
DE69632630T2 (de) 1995-03-16 2005-05-25 Novozymes A/S Enzym mit aminopeptidaseactivität
EP1214426A2 (en) 1999-08-31 2002-06-19 Novozymes A/S Novel proteases and variants thereof
US7618648B2 (en) * 2002-07-01 2009-11-17 Unilever Bestfoods, North America Division Of Conopco, Inc. Satiety inducing composition
US20060171992A1 (en) * 2002-12-20 2006-08-03 Gerhardt Cinderella C Blood glucose regulating composition
US7892808B2 (en) 2003-10-10 2011-02-22 Norozymes A/S Protease variants
JPWO2006132273A1 (ja) * 2005-06-08 2009-01-08 有限会社Ａ−ＨＩＴＢｉｏ 摂食抑制作用を有するペプチドを含有する組成物
US8431531B2 (en) * 2005-11-30 2013-04-30 Campina Nederland Holding B.V. Methods for stimulating glucagon-like peptide-1(GLP-1) secretion and treatments comprising same
US9034402B2 (en) * 2007-04-16 2015-05-19 Solae, Llc Protein hydrolysate compositions having improved sensory characteristics and physical properties

Also Published As

Publication number Publication date
JP2012513771A (ja) 2012-06-21
CA2747749A1 (en) 2010-07-08
CN102361560A (zh) 2012-02-22
EP2856885A3 (en) 2015-05-27
RU2011132135A (ru) 2013-02-10
EP2604125A1 (en) 2013-06-19
ES2429311T3 (es) 2013-11-14
BRPI0918708A2 (pt) 2015-08-25
US20110257087A1 (en) 2011-10-20
WO2010078461A1 (en) 2010-07-08
EP2856885A2 (en) 2015-04-08
SG172824A1 (en) 2011-08-29
EP2384125A1 (en) 2011-11-09
EP2384125B1 (en) 2013-07-17

Similar Documents

Publication Publication Date Title
MX2011007101A (es) Composiciones de hidrolizados proteicos que tienen capacidad mejorada para liberar colecistocinina (cck).
MY159396A (en) Compositions and methods for antibodies targeting complement protein c5
MX338884B (es) Composiciones y metodos que comprenden variantes de proteasa.
MX345909B (es) Anticuerpos anti-fgfr3 y métodos que los utilizan.
BRPI0922305A2 (pt) composições antitumorais contendo anticorpos que reconhecem, especialmente, cd38 e ciclofosfamida
MX2008001799A (es) Composicion farmaceutica que comprende un inhibidor de dipeptidil peptidasa iv.
ATE469895T1 (de) Cgrp-rezeptorantagonisten
EA201000844A1 (ru) Связывающие wise агенты и эпитопы
DE602007012072D1 (de) Orantagonisten
MX2009005829A (es) Polialquileniminas hidrofobicamente modificadas para usarse como inhibidores de transferencia de colorante.
IL214472A0 (en) Jun n-terminal kinase inhibitor compounds, compositions comprising the same and uses thereof
MX2013005062A (es) Composiciones pesticidas y procesos relacionados a las mimas.
GB0515353D0 (en) Food
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
EA201101116A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
MX341064B (es) Variantes de la familia il-1.
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
MY149433A (en) Nutritional compositions containing punicalagins
MY148915A (en) An extended-release composition comprising a somatostatin derivative in microparticles
MX2012000576A (es) Agentes anti-influenza.
MY165088A (en) Pharmaceutical compositions comprising alisporivir
UA96476C2 (ru) Фармацевтические композиции, которые содержат ирбесартан
NO20091386L (no) Fenyloksyanilinderivater

Legal Events

Date Code Title Description
FG Grant or registration